SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Momenta Pharmaceuticals Inc.
An SI Board Since March 2004
Posts SubjectMarks Bans Symbol
3027 64 0 MNTA
Emcee:  michael_f_murphy Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
2327Do you wanna hear what others think of you as well?mlkr-7/23/2010
2326My talent is for asking reasonably pertinent questions of people like you, Rick,tuck17/23/2010
2325Everyone has a unique talent, MLKR's is regurgitation :)rkrw-7/23/2010
2324You sure have a talent for regurgitation. Message 26705461 Why do you bother? tuck-7/23/2010
2323MNTA: Remarkable: Excellent job DD! Momenta Pharmaceuticals Announces Conferencmlkr-7/23/2010
2322The Natco product is a Copaxone knockoff, but it's not chemically identical DewDiligence_on_SI-7/23/2010
2321Although partner Natco is already selling a version in India & Ukraine. Smatuck-7/23/2010
2320Only MYL has filed, and no one I respect takes MYL's ANDA seriously.DewDiligence_on_SI-7/23/2010
2319Dew, you probably know this off the top of your head: who else has filed for gentuck-7/23/2010
2318My response to Teva’s response: siliconinvestor.com Regards, DewDewDiligence_on_SI-7/23/2010
2317Teva responds: >>JERUSALEM--(BUSINESS WIRE)--Teva Pharmaceutical Industrituck17/23/2010
2316Thanks, makes sense.fred hayes-7/23/2010
2315Since they have no patent they can't get an injunction. As far as an authorkrw-7/23/2010
2314Authorized generic issue has been kicked around more on IHub: siliconinvestor.ctuck17/23/2010
2313Don't know -- the authorized generic issue has been discussed in the past bufred hayes-7/23/2010
2312Still the possibility of SNY doing an authorized generic. Wheeler even mentionstuck-7/23/2010
2311Nope, which (if we're right) makes mnta still cheap.fred hayes17/23/2010
2310FDA monograph on requirements for generic enoxaparin; can Teva do this (hat tip tuck17/23/2010
2309Hardy congrats to mnta longs. It's been a long road...(:>)fred hayes-7/23/2010
2308CC at 1 PM eastern >>CAMBRIDGE, Mass., July 23, 2010 (GLOBE NEWSWIRE) -- tuck-7/23/2010
2307Trading now in the low to mid 20s, as though the market expects Teva to also gettuck-7/23/2010
2306They haven't restarted trading yet. I guess it'll be Monday until we fiJeffry K. Smith-7/23/2010
2305Unless the FDA site has been well spoofed, mEnoxaparin has been approved: fda.gtuck-7/23/2010
2304Momenta appears to have jumped a little and is now halted, so far as I can tell.tuck-7/23/2010
2303MNTA ‘ReadMeFirst’ updated: <i>2010-2011 news flow; handicapping the LoDewDiligence_on_SI-7/20/2010
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News